Reaction profile

The FDA adverse-event record for vials, abnormal

632 FDA reports name vials, abnormal, a high-volume reaction in the CVM extract (VeDDRA 99033). Plate stamps and neighbourhood peers follow.

#556 of 2,481
by report volume (all reactions)
632
reports citing this reaction
0.0%
death-coded share
Unknown
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Vials, Abnormal has 632 reports now versus 628 in that prior snapshot: 4 more (0.6%).

Report change
+4
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Vials, Abnormal changes

FDA AER · VeDDRA plate

Code 99033 VOL-MID

VOL-MID · DEATH-RARE · UPPER-Q · PHOTO-FINISH · SPECIES-UNKNOWN · DRUG-LEAD · DESK-MID · BOOK-FULL

  • VOL-MID 632 reports
  • DEATH-RARE 0.0%
  • UPPER-Q #556/2481
  • PHOTO-FINISH Abdominal mass
  • SPECIES-UNKNOWN Unknown · 622
  • DRUG-LEAD Moxidectin · 81
  • DESK-MID 4 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abdominal mass (±1 reports)

Upper-third report volume drives the scale stamps on this plate; death-coded share and co-report peers follow. Not a clinical diagnosis.

High-volume neighbourhood around Vials, Abnormal

Upper-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Circulatory collapse… · near636Weak pulse · near635Abdominal mass · near633Vials, Abnormal · this react…632Diabetic ketoacidosis · near631Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Vials, Abnormal

Vials, Abnormal: low death-coded share in the FDA AER plate

Signature read: Vials, Abnormal's 0.0% death-coded share is among the lowest in the openFDA reaction corpus. Report volume is upper-third scale: 632 named reports in the openFDA extract. Death-coded share is lower-third: 0 of 632 reports (0.0% of named reports). Nearest volume peer: Abdominal mass (±1 reports). Lead species Unknown (622). Lead co-reported drug Moxidectin (81).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Moxidectin appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Unknown 622
Human 7
Cat 1
Cattle 1
Dog 1

Breeds Most Affected

Unknown 629
Domestic (unspecified) 1
Holstein-Friesian also known as Holstein 1
Weimaraner 1

Associated Drugs

Moxidectin 81
Insulin Injectable Vial 80
Melarsomine Dihydrochloride Injection 76
Meloxicam 50
Prednisolone Sodium Succinate 45
Melarsomine Dihydrocloride Injectable 25Mg/Ml 18
Orbifloxacin 15
Velagliflozin Proline Monohydrate 13
Dirlotapide 12
Polysulfated Glycosaminoglycan 11
Protamine Zinc Recombinant Human Insulin 10
Cefovecin 10
Pimobendan 9
Ceftiofur Hydrochloride 9
Recombinant Human Insulin 9
Bupivacaine 9
Doramectin 8
Ceftiofur Sodium 8
Carprofen 7
Enrofloxacin 7

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Vials, Abnormal, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar death-coded share

Nearest other reactions by death-coded share (0.0% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Vials, Abnormal (#556 of 2,481 by report volume); death-coded 0.0%. PlainBreed reaction plate · death-coded share stamp 0.0% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →